Valeant Pharmaceuticals

Former Valeant and Philidor executives are sentenced to one year in prison
Former Valeant and Philidor executives are sentenced to one year in prison
Stat
Valeant Pharmaceuticals
Philidor Rx
kickbacks
Flag link:
Valeant Pharma's (VRX) Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
Valeant Pharma's (VRX) Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
Street Insider
Valeant Pharmaceuticals
Bausch + Lomb
FDA
sub-micron loteprednol etabonate
Flag link:
Valeant signs with WorldMeds to hawk first-ever opioid withdrawal drug Lucemyra
Valeant signs with WorldMeds to hawk first-ever opioid withdrawal drug Lucemyra
Fierce Pharma
US WorldMeds
FDA
Lucemyra
opioid withdrawal
Valeant Pharmaceuticals
Salix
Flag link:
Valeant shares drop 5% after FDA fails to approve plaque psoriasis lotion
Valeant shares drop 5% after FDA fails to approve plaque psoriasis lotion
Marketwatch
Valeant Pharmaceuticals
psoriasis
FDA
Duobrii
Flag link:
Kickback Allegation Settlements Pile Up for Pharmaceutical Companies
Kickback Allegation Settlements Pile Up for Pharmaceutical Companies
RAPS.org
kickbacks
Medicare
physicians
Pfizer
Jazz Pharmaceuticals
Valeant Pharmaceuticals
Shire
Omnicare
Flag link:
Ex-Valeant, Philidor executives found guilty of kickback scheme
Ex-Valeant, Philidor executives found guilty of kickback scheme
Business Insider
Valeant Pharmaceuticals
Philidor Rx
kickbacks
fraud
Gary Tanner
Flag link:
FDA calls out 39 drug companies for allegedly blocking access to generics
FDA calls out 39 drug companies for allegedly blocking access to generics
Stat
JNJ
Actelion
Celgene
Gilead
Novartis
Pfizer
Valeant Pharmaceuticals
generics
FDA
Flag link:
Valeant's ex-CEO jumped into Philidor deal even after being warned of potential collusion, jurors told
Valeant's ex-CEO jumped into Philidor deal even after being warned of potential collusion, jurors told
Fierce Pharma
Valeant Pharmaceuticals
Philidor Rx
Gary Tanner
Flag link:
Valeant will get a new name — again — hoping to shed its scandals
Valeant will get a new name — again — hoping to shed its scandals
Marketwatch
Valeant Pharmaceuticals
Bausch Health Companies
Flag link:
Will Ilumya Kill Valeant's Psoriasis Dreams?
Will Ilumya Kill Valeant's Psoriasis Dreams?
Seeking Alpha
Sun Pharma
Ilumya
FDA
psoriasis
Siliq
Valeant Pharmaceuticals
Flag link:
EyeGate Receives Milestone Payment for Completion of Enrollment in Ph III Study in Anterior Uveitis
EyeGate Receives Milestone Payment for Completion of Enrollment in Ph III Study in Anterior Uveitis
CP Wire
EyeGate Pharma
clinical trials
EGP-437
non-infectious anterior uveitis
Valeant Pharmaceuticals
Flag link:
After 2016's monster bonus—and investor complaints—Valeant CEO's pay crashes from $62M to $5M
After 2016's monster bonus—and investor complaints—Valeant CEO's pay crashes from $62M to $5M
Fierce Pharma
Valeant Pharmaceuticals
Pharma CEOs
Joseph Papa
executive pay
Flag link:
Teva, Valeant price-hike plans trigger warnings under California's new transparency law: report
Teva, Valeant price-hike plans trigger warnings under California's new transparency law: report
Fierce Pharma
Teva Pharmaceutical
Valeant Pharmaceuticals
drug pricing
California
transparency
Flag link:
Valeant Is Insolvent
Valeant Is Insolvent
NY Shock Exchange
Valeant Pharmaceuticals
Flag link:
5 Ways Valeant Pharmaceutical Plans to Turn Things Around
5 Ways Valeant Pharmaceutical Plans to Turn Things Around
Motley Fool
Valeant Pharmaceuticals
earnings
Ortho Dermatologics
debt
operational efficiency
R&D
Flag link:
Valeant shares slump even as drugmaker posts highest net profit in three years
Valeant shares slump even as drugmaker posts highest net profit in three years
Financial Post
Valeant Pharmaceuticals
earnings
Flag link:
Will Valeant Pharmaceuticals' Turnaround Fizzle with Its Q4 Results?
Will Valeant Pharmaceuticals' Turnaround Fizzle with Its Q4 Results?
Motley Fool
Valeant Pharmaceuticals
earnings
Flag link:
Patients Eagerly Awaited a Generic Drug. Then They Saw the Price.
Patients Eagerly Awaited a Generic Drug. Then They Saw the Price.
NY Times, NY
Teva Pharmaceuitcal
Syprine
drug pricing
Wilson disease
Valeant Pharmaceuticals
Flag link:
Valeant partner Cosmo turns wannabe IBS-D rival, and it could do some sales damage: analyst
Valeant partner Cosmo turns wannabe IBS-D rival, and it could do some sales damage: analyst
Fierce Pharma
Valeant Pharmaceuticals
Cosmo Pharma
rifamycin SV
IBS-d
Xifaxan
Flag link:
Why Valeant Pharmaceuticals Tumbled 10.9% Today
Why Valeant Pharmaceuticals Tumbled 10.9% Today
Motley Fool
Valeant Pharmaceuticals
analysts
Flag link:

Pages